SCHEMBL7712642

SCHEMBL7712642

Cc1cccc(Oc2c3cccc(Cl)c3cc3cccc(Cl)c23)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.40
ALDH1A1 P00352 3/20 0.39
ACHE P22303 4/20 0.38
HTT P42858 3/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 4/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2A6 P11509 1/20 0.36
LMNA P02545 4/20 0.36
TDP1 Q9NUW8 1/20 0.35
BCHE P06276 3/20 0.34
NPBWR1 P48145 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
BCL2 P10415 1/20 0.33
MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714721 0.87 CYP1A2 (0.37) L3MBTL1HTTNPSR1MAPTCYP1A2
SCHEMBL11429293 0.77 ACHE (0.52) L3MBTL1ALDH1A1ACHEHTTMEN1
SCHEMBL7712641 0.76 KMT2A (0.47) L3MBTL1ALDH1A1HTTMEN1KMT2A
SCHEMBL30463384 0.75 ALDH1A1 (0.55) L3MBTL1ALDH1A1ACHEHTTMEN1
SCHEMBL7712652 0.71 MAPT (0.46) L3MBTL1ALDH1A1HTTMEN1KMT2A
SCHEMBL7186960 0.69 CNR1 (0.37) L3MBTL1MEN1KMT2ACYP1A2CYP2A6
SCHEMBL11431172 0.69 L3MBTL1 (0.47) L3MBTL1ALDH1A1ACHEHTTMEN1
SCHEMBL10405354 0.68 CYP1A2 (0.52) ALDH1A1ACHEMEN1KMT2AKDM4E
SCHEMBL11423612 0.67 ALDH1A1 (0.64) L3MBTL1ALDH1A1ACHEHTTMEN1
SCHEMBL456868 0.67 ALDH1A1 (0.72) L3MBTL1ALDH1A1ACHEHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6369246-B2 ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS DR. KEITH CHAN, GLOBOASIA, LLC 2002-04-09 US disclosed
US-20010018539-A1 Synthesis and pharmaceuticals of novel 9-substituted-1, 5-dichloroanthracene analogs CHAN, KEITH 2001-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018539-A1 Synthesis and pharmaceuticals of novel 9-substituted-1, 5-dichloroanthracene analogs C3AR1, C5AR2, TLR2 L3MBTL1 4275/4885ALDH1A1 143/4885ACHE 2773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.